Oura and Counsel Expand AI-Driven Primary Care Partnership to Scale Chronic Disease Management for Medicare Beneficiaries

Smart wearable technology and artificial intelligence are officially stepping into the realm of federal healthcare delivery. Oura, the prominent health technology company widely recognized for its flagship Oura Ring, has announced a significant expansion of its strategic partnership with Counsel, an AI-native primary care provider. This new phase of collaboration is being facilitated through the Centers for Medicare & Medicaid Services (CMS) Innovation Center, specifically leveraging the newly established Advancing Chronic Care with Effective Scalable Solutions (ACCESS) Model.

By integrating continuous biometric data collection with proactive, physician-led clinical care, the initiative aims to study how modern technology and scalable care delivery models can effectively support Medicare beneficiaries struggling with prevalent chronic conditions. The landmark program is scheduled to officially launch in early 2027, bringing specialized, AI-assisted chronic care for hypertension, obesity, hyperlipidemia, and prediabetes to eligible Medicare beneficiaries across nearly all United States jurisdictions, completely free of out-of-pocket costs.

The Genesis of the Collaboration and Chronology of Growth

The partnership between Oura and Counsel is not entirely new; rather, this announcement represents the logical scaling of an alliance that initially took root earlier in the year. In May, the two companies joined forces to address a persistent gap in the consumer health landscape: the friction between passively collected biometric insights and actionable clinical intervention. Historically, wearable devices have excelled at gathering vast amounts of continuous physiological data—ranging from heart rate variability and sleep architecture to body temperature and activity levels. However, translating those data streams into meaningful healthcare guidance has often fallen squarely on the shoulders of the individual consumer.

The initial integration between Oura and Counsel allowed users to bridge that divide, seamlessly connecting the insights generated within the Oura App to licensed medical professionals capable of interpreting the data and recommending clinical next steps. Since that rollout, early adopters have reported high levels of satisfaction. According to internal metrics released by the partners, members who utilized the integration to consult with a physician rated their care experience an impressive 4.6 out of 5 stars, signaling strong approval for the convenience and clinical quality of the hybrid model.

Building upon this foundational success, the inclusion in the CMS ACCESS Model marks a massive escalation in scope. Moving from a direct-to-consumer feature integration to participation in a federal innovation model allows Oura and Counsel to test their hypothesis on a population-wide scale. Instead of relying solely on tech-savvy early adopters, the partnership will now reach deeper into the Medicare demographic—a population that bears a disproportionate share of the nation’s chronic disease burden.

Demographic Realities and the Focus on Cardio-Kidney-Metabolic Conditions

The decision to focus the ACCESS Model initiative on specific chronic conditions is rooted in clear epidemiological data. Hypertension, obesity, hyperlipidemia, and prediabetes are among the most pervasive health challenges facing older Americans, frequently intersecting to drive severe, long-term cardio-kidney-metabolic complications.

Crucially, demographic data from Oura indicates that older adults are among the platform’s most dedicated and engaged users. Members aged 65 and older exhibit exceptionally high daily app engagement rates, proving that older populations are fully capable and willing to embrace continuous health monitoring technology when provided with intuitive interfaces. Furthermore, internal data reveals that approximately 20 percent of Oura members within this specific age bracket present with a Body Mass Index (BMI) of 30 or higher. This statistical reality underscores the urgent necessity of targeted interventions focusing on weight management, metabolic health, and cardiovascular wellness.

Under the parameters of the upcoming ACCESS program, eligible Medicare beneficiaries will gain access to Counsel’s sophisticated medical artificial intelligence alongside on-demand access to board-certified physicians. For patients who choose to wear the Oura Ring and explicitly consent to share their biometric information, Counsel’s clinical team will leverage continuous health insights pulled directly from the Oura ecosystem. This ensures that treating physicians are not merely relying on intermittent, point-in-time measurements taken during an annual physical examination, but are instead informed by a rich, continuous longitudinal record of the patient’s daily physiological patterns.

Official Perspectives and Leadership Insights

Industry leaders from both organizations have emphasized the transformative potential of combining consumer-grade continuous monitoring with federal healthcare delivery frameworks.

"Earlier in the year, we partnered with Counsel to help Oura Members move from health insights to clinical action," noted Dr. Ricky Bloomfield, Chief Medical Officer at Oura. "The ACCESS program gives us the opportunity to study that model at scale, and to better understand how continuous biometric data, combined with physician-led care, can support Medicare beneficiaries managing hypertension, obesity, and other early cardio-kidney-metabolic conditions."

By participating in the CMS Innovation Center’s framework, Oura and Counsel are positioning themselves at the bleeding edge of value-based care and digital health integration. Federal innovation models are specifically designed to test novel payment and service delivery structures that have the potential to reduce program expenditures while preserving or enhancing the quality of care. If the continuous biometric model proves successful in managing chronic conditions within the Medicare population, it could serve as a blueprint for future federal healthcare policy regarding digital health therapeutics and wearable technology.

Enrollment Pathways and What Lies Ahead for Members

As the January 2027 launch date approaches, both companies are laying the operational groundwork necessary to streamline the onboarding process. The administrative workflow has been carefully structured to ensure regulatory compliance and clinical validity. Oura will act as an informational bridge, utilizing the Oura App to notify interested members about the availability of the ACCESS program and facilitating the initial connection to Counsel.

However, clinical screening and formal enrollment remain strictly under Counsel’s purview. Counsel will independently verify clinical eligibility according to CMS criteria, manage the official enrollment documentation, and oversee all aspects of patient care delivery. Detailed instructions and step-by-step guidance regarding how eligible Oura members can navigate this enrollment process directly through the Oura App will be released in the months leading up to the 2027 rollout.

Broader Implications for the Future of Digital Health and Medicare

The convergence of federal healthcare initiatives and consumer wearable technology signals a profound paradigm shift in how chronic disease is managed in the United States. For decades, the medical establishment viewed consumer health technology with skepticism, often dismissing continuous tracking as anecdotal or clinically irrelevant. Programs like the CMS ACCESS Model, however, reflect a growing institutional recognition that continuous real-world data can significantly augment traditional clinical workflows if properly integrated and interpreted by licensed professionals.

Chronic conditions like obesity and hypertension consume the vast majority of the nation’s healthcare expenditures, largely driven by acute exacerbations that require emergency intervention or hospitalization. By shifting toward proactive, data-informed primary care that targets early cardio-kidney-metabolic indicators, initiatives like the Oura-Counsel partnership aim to intercept disease progression before it results in catastrophic health events.

For Medicare beneficiaries, the program offers a high-touch, technologically advanced care experience entirely free of out-of-pocket costs—a vital consideration for fixed-income retirees navigating complex medical needs. For the healthcare system at large, the outcomes of this massive study will likely provide critical empirical data on whether artificial intelligence and wearable biometrics can successfully bend the cost curve of chronic disease management. As 2027 draws closer, all eyes will be on Oura and Counsel as they pioneer a new frontier in connected, patient-centric federal healthcare.